Description:

The most important information regarding the 158 new therapeutic agents marketed in the United States during the 2002-2008 period.

Comparisons with previously-marketed drugs with specific advantages and disadvantages identified.

New Drug Comparison Ratings (NDCR) for each new drug based on comparisons with related agents.